Table 8.
DXA Z-scores of adults.
Years following initiation of imiglucerase | Baseline DXA ≤−1 (n=68 patients, 253 assessments) |
||
---|---|---|---|
Predicted DXA Z-score | Lower 95% confidence interval | Upper 95% confidence interval | |
Baseline (−1 to<0) | −1.82 | −2.00 | −1.63 |
0 to<1 | −1.73 | −1.89 | −1.57 |
1 to <2 | −1.65 | −1.81 | −1.49 |
2 to <3 | −1.58 | −1.74 | −1.42 |
3 to <4 | −1.51 | −1.68 | −1.35 |
4 to <5 | −1.47 | −1.64 | −1.30 |
5 to <6 | −1.42 | −1.60 | −1.24 |
6 to <7 | −1.39 | −1.58 | −1.19 |
7 to <8 | −1.35 | −1.57 | −1.13 |
8 to <9 | −1.32 | −1.57 | −1.06 |
9 to <10 | −1.30 | −1.57 | −1.04 |
DXA Z-scores of patients with 2 or more measurements from a non-linear mixed model in adults (ages≥30 years to ≤50 years).